3623 results for «2453»
3623 results
PCR e-Course 2020 Clinical cases
25 Jun 2020 – From PCR e-Course 2020
Watch a series of best clinical cases presented at the PCR e-Course 2020:
- ACS-patient with culprit in a coronary ectasia
- Coronary stenting in an ectatic artery
- Challenging PCI after aortic valve-in-valve implantation
- Cisplatin-induced coronary artery thrombosis presented as ACS
- MOCA I study: microvascular obstruction measured using dMVR
- The many faces of in-stent...
The resurgence of renal denervation
25 Jun 2020 – From PCR e-Course
Following the latest trial results showing the safety and efficacy of renal denervation to treat hypertension, this session will provide you with a high-level update on where we stand currently and where we are moving in the near future.
This session was originally presented during PCR e-Course...
The burden of non-COVID patients: caring for the left-behind
26 Jun 2020 – From PCR e-Course 2020
Despite the dramatic consequences of the pandemic, there is still a need for treating chronic cardiovascular diseases. In this session, you will find out more about the strategies that can be used to deal with the people left behind.
This session was originally presented during PCR e-Course...
Vulnerable plaques and vulnerable patients
27 Jun 2020 – From PCR e-Course 2020
Watch this session to learn more about latest advances in detecting and treating vulnerable plaques and patients, in predicting clinical events, and the imaging options for prevention and treatment.
This session was originally presented during PCR e-Course 2020.
Mismatch between coronary anatomy and physiology
23 May 2019 – From EuroPCR 2019
Consult this session on mismatch between coronary anatomy and physiology to learn more about various studies, such as COMBINE (OCT-FFR), DOCTORS, and more!
Novel transcatheter prostheses for TAVI
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the clinical outcomes of novel transcatheter prostheses for TAVI, such as the 2nd generation Colibri, the self-expanding CENTERA, and more!
Complex aortoiliac bifurcation treatment - LIVE Case
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to select the best vascular access option (single versus multiple) and how to drive your device choice for patient-/lesion-individualised treatment.
LIVE demonstration from Clinique Pasteur - Toulouse, France
My Toolbox for iliac and femoral interventions with Benjamin Honton
22 May 2019 – From EuroPCR 2019
Consult this session to discover Benjamin Honton's toolbox for iliac and femoral interventions, depending on the disease's level. Learn more about the tools you need to enhance your clinical practice!
Coronary drug-coated balloons - Why, when and how
23 May 2019 – From EuroPCR 2019
Consult this session to discover practical tips about coronary drug-coated balloon, and learn more about its use, where it may provide a clinical benefit, and more!
Innovations in complex multivessel disease PCI – SYNTAX II strategy and beyond
23 May 2019 – From EuroPCR 2019
Consult this session on innovations in complex multivessel disease PCI to learn more about the recent innovations in physiology and IVUS guidance and to review current data on rotational atherectomy for calcified lesion preparation.
Reducing long term ischaemic events in high-risk patients: the role of intensified antithrombotic treatment
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the role of intensified antithrombotic treatment in improving cardiovascular outcomes in high-risk patients and how to implement this treatment.
Ability to treat diabetic patients: DES + DCB strategy
23 May 2019 – From EuroPCR 2019
Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.
New trials in coronary imaging and physiology
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the new trials and studies in coronary imaging and physiology: FFR-Search, ROCK II, HAWKEYE, and more!
RADIANCE-HTN SOLO: six-month results of renal denervation in patients on medications using the ReCor Paradise endovascular ultrasound system in a randomised, blinded, sham-controlled study
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the latest results from the RADIANCE-HTN SOLO cohort at the 6-month time point to assess efficacy of renal denervation in patients after medication titration.
PCI complications in daily practice: patient, device or doctor?
23 May 2019 – From EuroPCR 2019
Consult this session on PCI complications in daily practice and learn through compelling cases all about the successful and unsuccessful steps taken to solve adverse events.
Precision meets simplicity – Complex PCI guided by a 2nd generation fibre optic physiology guidewire
23 May 2019 – From EuroPCR 2019
Consult this session to learn through various compelling clinical cases how the new OptoWire physiology guidewire can make the difference compared to the current pressurewires, and how to use it in bifurcations, serial lesions and CAD and aortic stenoses.
Nightmare complications of left main PCI
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to anticipate and prevent severe left main complications and how to successfully manage left main complications such as dissection, perforation and stent loss.
Latest developments in cerebral embolic protection
23 May 2019 – From EuroPCR 2019
Consult this session to hear the latest update on the US REFLECT phase II trial, to learn about the EU experience with the TriGUARD 3 CEP device and to learn about Keystone Heart's EU roadmap.
Innovations in TAVI: new valves, new procedures
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the innovations in TAVI from 2019, regarding valves and procedures, such as AorticLab system, FACTA technology, and more!
Complex PCI in high bleeding risk patients
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to identify high bleeding risk (HBR) patients requiring adjusted antithrombotic strategy and how to tailor PCI strategies to specific HBR patient for drug-device synergy.
